The fluid-cooled radiofrequency ablation market size has grown strongly in recent years. It will grow from $2.79 billion in 2025 to $3.06 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to limited availability of internally cooled rf ablation devices, reliance on conventional rf ablation systems, growing prevalence of cardiac arrhythmias and tumors, increasing hospital and surgical center infrastructure, adoption of standard accessory products.
The fluid-cooled radiofrequency ablation market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to technological advancements in fluid-cooling systems, rising investment in minimally invasive procedures, increasing integration of imaging and real-time feedback technologies, expansion of oncology and cardiology procedures, growing awareness and adoption in ambulatory surgical centers and specialty clinics. Major trends in the forecast period include increasing adoption of fluid-cooled rf ablation for cardiology and oncology, development of monopolar and bipolar rf ablation devices, integration of real-time feedback systems for precise tissue ablation, growth in use of accessory products such as catheters and electrodes, rising demand for closed-loop and disposable cooling systems.
The increasing prevalence of chronic diseases is expected to drive the growth of the fluid-cooled radiofrequency ablation market in the coming years. Chronic diseases are long-term health conditions that generally last for one year or longer, require continuous medical management, and may restrict daily activities. The rise in chronic diseases is largely attributed to the aging population, as older individuals are more susceptible to prolonged health conditions. Fluid-cooled radiofrequency ablation supports the management of chronic diseases by precisely delivering thermal energy to nerve tissues to interrupt pain signaling, offering sustained pain relief for conditions such as chronic back pain and arthritis. For example, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic conditions were responsible for an estimated 4.4 million years of healthy life lost among Australians in 2023, accounting for 85% of the country’s total disease burden for that year. Therefore, the rising prevalence of chronic diseases is fueling the growth of the fluid-cooled radiofrequency ablation market.
The expanding geriatric population is expected to further drive growth in the fluid-cooled radiofrequency ablation market going forward. The geriatric population includes individuals aged 65 years and above, representing older adults who often require specialized healthcare services, social support, and targeted policies due to age-related physiological, medical, and functional needs. The growth of the geriatric population is primarily driven by increased life expectancy resulting from advancements in healthcare, which enable people to live longer and contribute to a higher proportion of individuals entering older age groups. Fluid-cooled radiofrequency ablation benefits the geriatric population by offering a minimally invasive and highly effective pain management solution that minimizes tissue damage and promotes faster recovery, thereby enhancing mobility and overall quality of life for older adults. For instance, in January 2024, according to a report published by the World Bank, a United States-based economic data organization, approximately 17.4% of the U.S. population comprised individuals aged 65 and older in 2023. Therefore, the growing geriatric population is driving the growth of the fluid-cooled radiofrequency ablation market.
Companies operating in the fluid-cooled radiofrequency ablation market are concentrating on introducing innovative products, such as internally cooled radiofrequency ablation systems, to improve heat dissipation, enhance procedural accuracy, and reduce damage to nearby healthy tissues. Internally cooled radiofrequency ablation systems are medical devices that transmit RF energy to ablate tissue while circulating fluid inside the electrode to prevent overheating and allow deeper, more effective treatment. In March 2024, Medtronic Plc obtained FDA 510(k) clearance for its OsteoCool 2 bone tumor ablation system, designed to enhance the treatment of painful bone tumors with improved precision and efficiency. This system enables the simultaneous use of four internally cooled probes, facilitating the ablation of multiple vertebral bodies or the creation of larger ablation zones. Delivering 20 watts per channel, it is the most powerful bone tumor ablation system available, increasing tumor destruction efficiency. Its internal water-cooling feature ensures consistent ablations while minimizing the risk of overheating surrounding tissues, making the procedure safer. The OsteoCool 2 is intended to provide effective pain relief and palliative care for malignant bone metastases and benign tumors, such as osteoid osteoma, improving patient outcomes through minimally invasive techniques.
Major companies operating in the fluid-cooled radiofrequency ablation market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Lepu Medical Technology, MicroPort Scientific Corporation, Avanos Medical, Japan Lifeline Co. Ltd., AtriCure Inc, AngioDynamics, SyMap Medical, CardioFocus Inc, Imricor Medical Systems Inc., Stereotaxis Inc., Autonomix Medical, Innoblative Designs Inc, livetec Ingenieurbüro GmbH.
North America was the largest region in the fluid-cooled radiofrequency ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluid-cooled radiofrequency ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fluid-cooled radiofrequency ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the fluid-cooled radiofrequency ablation market by increasing the cost of imported devices, accessory products, and fluid-cooling systems. Segments such as internally cooled rf ablation devices and closed-loop cooling systems are particularly impacted, with major manufacturing regions in Asia-Pacific including China and India facing higher import duties. This has led to increased production costs and supply chain adjustments. On the positive side, tariffs are driving local manufacturing initiatives, encouraging innovation in device and cooling system designs, and promoting investment in domestic production capabilities.
The fluid-cooled radiofrequency ablation market research report is one of a series of new reports that provides fluid-cooled radiofrequency ablation market statistics, including fluid-cooled radiofrequency ablation industry global market size, regional shares, competitors with a fluid-cooled radiofrequency ablation market share, detailed fluid-cooled radiofrequency ablation market segments, market trends and opportunities, and any further data you may need to thrive in the fluid-cooled radiofrequency ablation industry. This fluid-cooled radiofrequency ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Fluid-cooled radiofrequency ablation is a medical technique that employs internally cooled electrodes to deliver controlled heat for accurate tissue ablation, most commonly in the treatment of cardiac arrhythmias or tumors. This method involves circulating fluid within the electrode to cool its tip, enabling deeper and more regulated thermal energy delivery for effective ablation of targeted tissue.
The primary categories of fluid-cooled radiofrequency ablation include radiofrequency ablation devices, accessory components, and fluid-cooling systems. Radiofrequency ablation (RFA) devices are specialized medical instruments that utilize high-frequency electrical energy to produce heat and eliminate targeted abnormal tissues for therapeutic purposes. These devices often incorporate advanced features such as integrated imaging and real-time feedback systems. The targeted tissues generally include solid tumors, soft tissue tumors, and bone tumors. These systems are applied across multiple medical specialties, including cardiology, oncology, pain management, and urology, and are frequently used in hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.
The fluid-cooled radiofrequency ablation market consists of revenues earned by entities providing services such as cardiac arrhythmia treatment, tumor ablation therapy, pain management procedures, pulmonary vein isolation, and clinical training and device support. The market value includes the value of related goods sold by the service provider or included within the service offering. The fluid-cooled radiofrequency ablation market also includes sales of products such as radiofrequency generators, cooled ablation catheters, irrigation pumps, temperature monitoring systems, and electrode cables. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The fluid-cooled radiofrequency ablation market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to technological advancements in fluid-cooling systems, rising investment in minimally invasive procedures, increasing integration of imaging and real-time feedback technologies, expansion of oncology and cardiology procedures, growing awareness and adoption in ambulatory surgical centers and specialty clinics. Major trends in the forecast period include increasing adoption of fluid-cooled rf ablation for cardiology and oncology, development of monopolar and bipolar rf ablation devices, integration of real-time feedback systems for precise tissue ablation, growth in use of accessory products such as catheters and electrodes, rising demand for closed-loop and disposable cooling systems.
The increasing prevalence of chronic diseases is expected to drive the growth of the fluid-cooled radiofrequency ablation market in the coming years. Chronic diseases are long-term health conditions that generally last for one year or longer, require continuous medical management, and may restrict daily activities. The rise in chronic diseases is largely attributed to the aging population, as older individuals are more susceptible to prolonged health conditions. Fluid-cooled radiofrequency ablation supports the management of chronic diseases by precisely delivering thermal energy to nerve tissues to interrupt pain signaling, offering sustained pain relief for conditions such as chronic back pain and arthritis. For example, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic conditions were responsible for an estimated 4.4 million years of healthy life lost among Australians in 2023, accounting for 85% of the country’s total disease burden for that year. Therefore, the rising prevalence of chronic diseases is fueling the growth of the fluid-cooled radiofrequency ablation market.
The expanding geriatric population is expected to further drive growth in the fluid-cooled radiofrequency ablation market going forward. The geriatric population includes individuals aged 65 years and above, representing older adults who often require specialized healthcare services, social support, and targeted policies due to age-related physiological, medical, and functional needs. The growth of the geriatric population is primarily driven by increased life expectancy resulting from advancements in healthcare, which enable people to live longer and contribute to a higher proportion of individuals entering older age groups. Fluid-cooled radiofrequency ablation benefits the geriatric population by offering a minimally invasive and highly effective pain management solution that minimizes tissue damage and promotes faster recovery, thereby enhancing mobility and overall quality of life for older adults. For instance, in January 2024, according to a report published by the World Bank, a United States-based economic data organization, approximately 17.4% of the U.S. population comprised individuals aged 65 and older in 2023. Therefore, the growing geriatric population is driving the growth of the fluid-cooled radiofrequency ablation market.
Companies operating in the fluid-cooled radiofrequency ablation market are concentrating on introducing innovative products, such as internally cooled radiofrequency ablation systems, to improve heat dissipation, enhance procedural accuracy, and reduce damage to nearby healthy tissues. Internally cooled radiofrequency ablation systems are medical devices that transmit RF energy to ablate tissue while circulating fluid inside the electrode to prevent overheating and allow deeper, more effective treatment. In March 2024, Medtronic Plc obtained FDA 510(k) clearance for its OsteoCool 2 bone tumor ablation system, designed to enhance the treatment of painful bone tumors with improved precision and efficiency. This system enables the simultaneous use of four internally cooled probes, facilitating the ablation of multiple vertebral bodies or the creation of larger ablation zones. Delivering 20 watts per channel, it is the most powerful bone tumor ablation system available, increasing tumor destruction efficiency. Its internal water-cooling feature ensures consistent ablations while minimizing the risk of overheating surrounding tissues, making the procedure safer. The OsteoCool 2 is intended to provide effective pain relief and palliative care for malignant bone metastases and benign tumors, such as osteoid osteoma, improving patient outcomes through minimally invasive techniques.
Major companies operating in the fluid-cooled radiofrequency ablation market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Lepu Medical Technology, MicroPort Scientific Corporation, Avanos Medical, Japan Lifeline Co. Ltd., AtriCure Inc, AngioDynamics, SyMap Medical, CardioFocus Inc, Imricor Medical Systems Inc., Stereotaxis Inc., Autonomix Medical, Innoblative Designs Inc, livetec Ingenieurbüro GmbH.
North America was the largest region in the fluid-cooled radiofrequency ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluid-cooled radiofrequency ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fluid-cooled radiofrequency ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the fluid-cooled radiofrequency ablation market by increasing the cost of imported devices, accessory products, and fluid-cooling systems. Segments such as internally cooled rf ablation devices and closed-loop cooling systems are particularly impacted, with major manufacturing regions in Asia-Pacific including China and India facing higher import duties. This has led to increased production costs and supply chain adjustments. On the positive side, tariffs are driving local manufacturing initiatives, encouraging innovation in device and cooling system designs, and promoting investment in domestic production capabilities.
The fluid-cooled radiofrequency ablation market research report is one of a series of new reports that provides fluid-cooled radiofrequency ablation market statistics, including fluid-cooled radiofrequency ablation industry global market size, regional shares, competitors with a fluid-cooled radiofrequency ablation market share, detailed fluid-cooled radiofrequency ablation market segments, market trends and opportunities, and any further data you may need to thrive in the fluid-cooled radiofrequency ablation industry. This fluid-cooled radiofrequency ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Fluid-cooled radiofrequency ablation is a medical technique that employs internally cooled electrodes to deliver controlled heat for accurate tissue ablation, most commonly in the treatment of cardiac arrhythmias or tumors. This method involves circulating fluid within the electrode to cool its tip, enabling deeper and more regulated thermal energy delivery for effective ablation of targeted tissue.
The primary categories of fluid-cooled radiofrequency ablation include radiofrequency ablation devices, accessory components, and fluid-cooling systems. Radiofrequency ablation (RFA) devices are specialized medical instruments that utilize high-frequency electrical energy to produce heat and eliminate targeted abnormal tissues for therapeutic purposes. These devices often incorporate advanced features such as integrated imaging and real-time feedback systems. The targeted tissues generally include solid tumors, soft tissue tumors, and bone tumors. These systems are applied across multiple medical specialties, including cardiology, oncology, pain management, and urology, and are frequently used in hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.
The fluid-cooled radiofrequency ablation market consists of revenues earned by entities providing services such as cardiac arrhythmia treatment, tumor ablation therapy, pain management procedures, pulmonary vein isolation, and clinical training and device support. The market value includes the value of related goods sold by the service provider or included within the service offering. The fluid-cooled radiofrequency ablation market also includes sales of products such as radiofrequency generators, cooled ablation catheters, irrigation pumps, temperature monitoring systems, and electrode cables. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Fluid-Cooled Radiofrequency Ablation Market Characteristics
3. Fluid-Cooled Radiofrequency Ablation Market Supply Chain Analysis
4. Global Fluid-Cooled Radiofrequency Ablation Market Trends and Strategies
5. Fluid-Cooled Radiofrequency Ablation Market Analysis of End Use Industries
7. Global Fluid-Cooled Radiofrequency Ablation Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Fluid-Cooled Radiofrequency Ablation Total Addressable Market (TAM) Analysis for the Market
9. Fluid-Cooled Radiofrequency Ablation Market Segmentation
10. Fluid-Cooled Radiofrequency Ablation Market Regional and Country Analysis
11. Asia-Pacific Fluid-Cooled Radiofrequency Ablation Market
12. China Fluid-Cooled Radiofrequency Ablation Market
13. India Fluid-Cooled Radiofrequency Ablation Market
14. Japan Fluid-Cooled Radiofrequency Ablation Market
15. Australia Fluid-Cooled Radiofrequency Ablation Market
16. Indonesia Fluid-Cooled Radiofrequency Ablation Market
17. South Korea Fluid-Cooled Radiofrequency Ablation Market
18. Taiwan Fluid-Cooled Radiofrequency Ablation Market
19. South East Asia Fluid-Cooled Radiofrequency Ablation Market
20. Western Europe Fluid-Cooled Radiofrequency Ablation Market
21. UK Fluid-Cooled Radiofrequency Ablation Market
22. Germany Fluid-Cooled Radiofrequency Ablation Market
23. France Fluid-Cooled Radiofrequency Ablation Market
24. Italy Fluid-Cooled Radiofrequency Ablation Market
25. Spain Fluid-Cooled Radiofrequency Ablation Market
26. Eastern Europe Fluid-Cooled Radiofrequency Ablation Market
27. Russia Fluid-Cooled Radiofrequency Ablation Market
28. North America Fluid-Cooled Radiofrequency Ablation Market
29. USA Fluid-Cooled Radiofrequency Ablation Market
30. Canada Fluid-Cooled Radiofrequency Ablation Market
31. South America Fluid-Cooled Radiofrequency Ablation Market
32. Brazil Fluid-Cooled Radiofrequency Ablation Market
33. Middle East Fluid-Cooled Radiofrequency Ablation Market
34. Africa Fluid-Cooled Radiofrequency Ablation Market
36. Fluid-Cooled Radiofrequency Ablation Market Competitive Landscape and Company Profiles
37. Fluid-Cooled Radiofrequency Ablation Market Other Major and Innovative Companies
40. Fluid-Cooled Radiofrequency Ablation Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Fluid-Cooled Radiofrequency Ablation Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses fluid-cooled radiofrequency ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for fluid-cooled radiofrequency ablation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fluid-cooled radiofrequency ablation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Radiofrequency Ablation Devices; Accessory Products; Fluid-Cooling Systems2) By Technology: Integrated Imaging Technology; Real-Time Feedback Systems
3) By Target Tissue: Solid Tumors; Soft Tissue Tumors; Bone Tumors
4) By Application: Cardiology; Oncology; Pain Management; Urology; Other Applications
5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Radiofrequency Ablation Devices: Monopolar Radiofrequency Ablation Devices; Bipolar Radiofrequency Ablation Devices; Internally Cooled Radiofrequency Ablation Devices2) By Accessory Products: Radiofrequency Ablation Catheters; Radiofrequency Ablation Electrodes; Introducers And Sheaths
3) By Fluid-Cooling Systems: Peristaltic Pump Systems; Closed-Loop Cooling Systems; Disposable Tubing Sets
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; CONMED Corporation; Lepu Medical Technology; MicroPort Scientific Corporation; Avanos Medical; Japan Lifeline Co. Ltd.; AtriCure Inc; AngioDynamics; SyMap Medical; CardioFocus Inc; Imricor Medical Systems Inc.; Stereotaxis Inc.; Autonomix Medical; Innoblative Designs Inc; livetec Ingenieurbüro GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Fluid-Cooled Radiofrequency Ablation market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- Olympus Corporation
- CONMED Corporation
- Lepu Medical Technology
- MicroPort Scientific Corporation
- Avanos Medical
- Japan Lifeline Co. Ltd.
- AtriCure Inc
- AngioDynamics
- SyMap Medical
- CardioFocus Inc
- Imricor Medical Systems Inc.
- Stereotaxis Inc.
- Autonomix Medical
- Innoblative Designs Inc
- livetec Ingenieurbüro GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.06 Billion |
| Forecasted Market Value ( USD | $ 4.34 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
